SCHEMBL4396126

SCHEMBL4396126

C=CCOC(=O)C(F)(Br)Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
TSHR P16473 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPT P10636 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SNCA P37840 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
APP P05067 1/20 0.33
RHOA P61586 1/20 0.32
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1980397 0.87 CYP3A4 (0.42) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL1082749 0.82 CYP3A4 (0.41) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL8207148 0.82 CYP3A4 (0.41) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL7095889 0.82 CYP3A4 (0.45) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL11444238 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HSD17B10MAPT
Ammonia Solution, Strong SCHEMBL11233126 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL28761387 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL29506833 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL28427366 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HSD17B10MAPT
SCHEMBL22592255 0.78 MAPT (0.40) CYP3A4TSHRALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027138-B1 STABLE C-GLYCOSIDE SUGAR AND C-GLYCOCONJUGATE MIMETICS, METHOD FOR PREPARING SAME AND USES THEREOF IN PARTICULAR IN COSMETICS AND DRUGS TFCHEM (FR) 2012-12-05 EP claimed
US-20090318678-A1 Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs TFCHEM (FR) 2009-12-24 US claimed
US-20090318678-A1 Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs TFCHEM (FR) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318678-A1 Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs CA7, GPR119, SLC5A2 CYP3A4 3222/4885TSHR 325/4885ALDH1A1 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.